Another Compounding Pharmacy Recalls All Sterile Product

Megan Brooks


May 30, 2013

Lowlite Investments Inc, doing business as Olympia Pharmacy in Orlando, Florida, has initiated a voluntary recall of all unexpired sterile drug products compounded by the pharmacy because of a lack of sterility assurance.

"The recall is being initiated due to concerns associated with prior quality control procedures that impacted sterility," the company says in a press release posted May 29 on the FDA Web site.

The affected product was compounded between December 17, 2012, and March 27, 2013. The recall includes all sterile products that Lowlite supplied to patients and offices of licensed medical professionals with a use-by date of September 25, 2013, or earlier.

A complete list of the recalled products, lot numbers and expiration dates can be found on the FDA Web site.

The recall is being conducted as a "precautionary measure," the company says. To date, they have not received any reports of injury or illness associated with the recalled product. However, "in the event a sterile product is compromised patients are at risk for serious and possible life threatening infections."

Lowlite is notifying customers by telephone, fax, or mail to return the products to the pharmacy.

Consumers or healthcare providers with questions regarding this recall may contact Lowlite by telephone at 888-323-7788 or 407-673-2222 between 9:00 AM and 6:00 PM Eastern Daylight Time Monday through Friday, or by e-mail to

The recall of sterile product at Olympia Pharmacy follows recent recalls of sterile products at other compounding pharmacies for similar problems and concerns about sterility of products.

As reported by Medscape Medical News, those companies include The Compounding Shop of St. Petersburg, Florida; ApothéCure Inc and NuVision Pharmacy, both of Dallas, Texas; Green Valley Drugs in Henderson, Nevada; and Balanced Solutions Compounding Pharmacy of Lake Mary, Florida.

Adverse reactions or quality problems experienced with the use of Olympia Pharmacy products or other products may be reported to MedWatch, the FDA's safety information and adverse event reporting program, by telephone at 1-800-FDA-1088; by fax at 1-800-FDA-0178; online at; with postage-paid FDA form 3500, available at; or by mail to MedWatch, 5600 Fishers Lane, Rockville, Maryland 20852-9787.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: